Agencia Gaston

Beginning July 1, 2026, eligible federal prescription coverage members may access GLP-1 weight-loss prescriptions with a flat $50 monthly copay at pharmacies.
The short-term pilot runs through Late-Q4 2027, bridging possible longer-term coverage that may or may not begin in 2028 for eligible patients.
Eligibility Snapshot
Federal drug coverage enrollment required
BMI 27+ with qualifying condition
BMI 35+ qualifies automatically
Prior authorization uses a central federal contractor system; approved patients pay $50, but copays exclude deductible, $2.1K cap credit, and low-income assistance.
After Late-Q4 2027, coverage remains uncertain, and stopping GLP-1 therapy often leads to regained weight, making continuity planning important for patients and prescribers.

New Federal GLP-1 Cost Option

Nationwide homeowners insurance premiums are expected to keep rising in 2026, with avg. annual costs projected ↑4% to ~$3K for many US households.
Costs are climbing nationwide as natural disasters grow more frequent and severe, while repairs, materials, labor, and local factors also add pressure.
Higher premiums are increasingly flowing into monthly mortgage payments through escrow, so insurance budgeting now matters alongside principal, interest, and taxes for homeowners.
First-time buyers may feel the pressure most, because rising insurance costs can affect affordability calculations early in the homebuying process for new households.
Coverage changes remain another watch point: some insurers are cutting coverage, refusing renewals, or restructuring policies to shift more risk toward homeowners.